# A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

> **NCT00731250** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 45 (actual)

## Conditions studied

- Rhinitis

## Interventions

- **DRUG:** SB-705498
- **DRUG:** Placebo
- **OTHER:** Caspaicin

## Key facts

- **NCT ID:** NCT00731250
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-22
- **Primary completion:** 2009-03-01
- **Final completion:** 2009-03-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00731250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00731250, "A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00731250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*